Injecting nanoparticles carrying a gene that produces an altered form of diphtheria toxin to specifically destroy ovarian cancer cells in diseased mice proved effective compared with combining chemotherapy drugs cisplatin and paclitaxel, U.S. scientists found. They said the treatment could be tested in humans within a year.

Full Story:

Related Summaries